UAE to manufacture Covid-19 vaccine Hayat-Vax from Sinopharm vaccine

UAE to manufacture Covid-19 vaccine Hayat-Vax from Sinopharm vaccine

A new factory in Abu Dhabi will start manufacturing a Covid-19 vaccine from Chinese pharmaceutical giant, Sinopharm, under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42 (G42).The vaccine will be called Hayat-Vax when manufactured in the UAE, but is the same inactivated vaccine from the Beijing Institute of Biological Product (BiBP), a unit of Sinopharm's China National Biotec Group (CNBG).Production of Hayat-Vax has already begun in the emirate of Ras al-Khaimah under a deal between G42 and Gulf Pharmaceutical Industries PSC. That production line has an initial capacity of 2 million doses per month.Comments Read Next13 hours agoUAE to manufacture Sinopharm vaccine2 days agoSerum Institute delays launch of Novavax vaccine in India2 days agoBahrain urges citizens, residents to take available COVID-19 vaccines2 days agoWHO: AstraZeneca vaccine still safe to use3 days agoUAE administers 69,142 vaccine doses in 24 hours4 days agoPfizer, BioNTech launch vaccine trial in kids under 124 days agoUAE: PCR tests reduced to AED 655 days agoSaudi: Mandatory health insurance for all members of worker's family5 days agoKuwait: Schools to reopen in September5 days agoSaudi Arabia: Mandatory immunization for all transport workers